However, in the present study, after over 10 years of follow-up observation conducted among 200 breast cancer patients, it was noted that high expression of both cytoplasmic and nucleus CXCR4 often indicated worse prognosis. The gene discussed is CXCR4; the disease is breast carcinoma.